Effect of DSG on xenogeneic immune reactivity with special emphasis on human anti-pig cellular reactions in vitro

Xenotransplantation

Volumn 3, Issue 2, 1996, Pages 171-178

  Borg, Anette Johansson ^a   Kumagai Braesch, Makiko ^a   Möller, Erna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anti pig; CsA; DSG; FK506; Human; Immune; Reactions; Xenotransplantation

Indexed keywords

EID: 0041491741     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00135.x     Document Type: Article

References (48)

1. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute rejection in a swine-to-primate model. Transplantation 1991:52:214.
2. SATAKE M, KORSGREN O, RIDDERSTAD A, KARLSSON-PARRA A, WALLGREN AC, MÖLLER E. Immunological characteristics of islet cell xenotransplantation in humans and rodents. Immunol Rev 1994:141:191.
3. SATAKE M, KAWAGISHI N, MÖLLER E. Direct activation of human responder T cell by porcine stimulator cells leads to T cell proliferation and CTL development. Xenotransplantation, submitted.
4. STOCK PG, ASCHER NL, CHEN S, FIELD J, BACH FH, SUTHERLAND DER. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation 1991:52:704.
5. SATA KE M, KUMAGAI-BRAESCH M, KAWAGISHI N, TIBELL A, GROTH C-G, MÖLLER E. Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet clusters. Xeno 1994:1:24.
6. CORRY RJ, CUTKOMP J, OBERHOLSER JH, KAPELANSKI DP, WAKELY E. Prolongation of allograft and xenograft survival with 15-deoxyspergualin. Transplant Proc 1989:21:530.
7. OCHIAI T, NAKAJIMA K, SAKAMOTO K, NAGATA M, GUNJI Y, ASANO T, ISONO K, SAKAMAKI T, HAMAGUCHI K. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Transplant Proc 1989:21:829.
8. GROTH CG, KORSGREN O, TIBELL A, TOLLEMAR J, MÖLLER E, BOLINDER J, ÖSTMAN J, REINHOLT FP, HELLERSTRÖM C, ANDERSSON A. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994:344:1402.
9. KUMAGAI-BRAESCH M, BORG AJ, MÖLLER E. Direct and indirect pathway of antigen presentation in xenogeneic MLC. Effect of immunosuppressive drugs. Manuscript in preparation.
10. ITO S, UENO M, ARAKAWA M, SAITO T, AOYAGI T, FUJIWARA M. Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses. Clin Exp Immunol 1990:81:446.
11. MORIKAWA K, OSEKO F, MORIKAWA S. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells. Transplantation 1992:54:526.
12. MAKINO M, FUJIWARA M, WATANABE H, AOYAGI T, UMEZAWA H. Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. Immunopharmacology 1987:14:115.
13. VALDIVIA LA, MONDEN M, GOTOH M, NAKANO Y, TONO T, MORI T. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation 1990:50:132.
14. AUCHINCLOSS H. Xenogeneic transplantation. A review. Transplantation 1988:46:1.
15. CALNE RY. Organ transplantation between widely disparate species. Transplant Proc 1970:2:550.
16. SATAKE M, KUMAGAI-BRAESCH M, KORSGREN O, ANDERSSON A, MÖLLER E. Characterization of humoral human anti-porcine xenoreactivity. Clin Transplant 1993:7:281.
17. KUMAGAI-BRAESCH M, SATAKE M, KORSGREN O, ANDERSSON A, MÖLLER E. Characterization of cellular human anti-porcine xenoreactivity. Clin Transplant 1993:7:273.
18. JOHANSSON A, MÖLLER E. Evidence that the immunosuppressive effects of FK506 and cyclosporin are identical. Transplantation 1990:50:1001.
19. LIN CS, BOLTZ RC, SIEKIERKA JJ, SIGAL NH. FK506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol 1991:133.
20. HANDSCHUMACHER RE, HARDING MW, RICE J, DRUGGE RJ. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984:226:544.
21. HARDING MW, GALAT A, UEHLING DE, SCHREIBER SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989:341:758.
22. SIERKIERKA JJ, HUNG SHY, POE M, LIN CS, SIGAL NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989:341:755.
23. LIU J, FRAMER JD, LANE WS, FRIEDMAN J, WEISSMAN I, SCHREIBER SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991:66:807.
24. FRUMAN DA, KLEE CB, BIERER BE, BURAKOFF SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992:89:3686.
25. FLANAGAN WM, CORTHÉSY B, BRAM RJ, CRABTREE GR. Nuclear association of a T-cell transcription factor blocked by FK506 and cyclosporin A. Nature 1991:352:803.
26. CLIPSTONE NA, CRABTREE GR. Identification of calcineurin as a key signalling enzyme in T-lymphocytes activation. Nature 1992:357:695.
27. TUFVESSON G, GANNEDAHL G. Deoxyspergualin - a different and intriguing immunosuppressant. Transplant Proc 1994:26:3029.
28. NADEAU K, NADLER SG, SAULNIER M, TEPPER MA, WALSH CT. Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry 1994:33:2561.
29. Thomas FD. Pancreas islet transplantation. Curr Surg 1991:48:343.
30. SANDBERG J-O, KORSGREN O, GROTH C-G, ANDERSSON A. 15-deoxyspergualin prolongs pancreatic islet allo- and xenograft survival in mice. Pharmacol Toxicol 1993:73:24.
31. DICKNEITE G, SCHORLEMMER HU, WALTER P, THIES J, SEDLACEK HH. The influence of (±)-15-deoxyspergualin on experimental transplantation and its immunopharmacological mode of action. Behring Inst Mitt 1986:80:93.
32. + T lymphocytes in primary nonfunction and classical rejection of islet allografts. J Exp Med 1990:172:291.
33. FUJI H, TAKADA T, NEMOTO K, ABE F, TAKEUCHI T. Stability and immunosuppressive activity of deoxyspergualin in comparison with deoxymethylspergualin. Transplant Proc 1989:21:3471.
34. NISHIMURA K, TOKUNAGA T. Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro. Immunology 1989:68:66.
35. KERR PG, ATKINS RC. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells. Immunol Cell Biol 1991:69:177.
36. TEPPER MA, NADLER S, MAZZUCCO C, SINGH C, KELLEY SL. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action. Ann NY Acad Sci 1993:685:136.
37. TAKAHARA S, JIANG H, TAKANO Y, KOKADO Y, ISHOBASHI M, OKUYAMA A, SONODA T. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. Transplantation 1992:53:914.
38. BORG AJ, KUMAGAI-BRAESCH M, MÖLLER E. 15-Deoxyspergualin inhibits interleukin-6 production in vitro stimulated human lymphocytes. Transplant Immunol., in press.
39. TAKAI Y, WONG GG, CLARK SC, BURAKOFF SJ, HERRMANN SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol 1988:140:508.
40. OKADA M, KITAHARA M, KISHIMOTO S, MATSUDA T, HIRANO T, KISHIMOTO T. Il-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988:141:1543.
41. HOEGER PH, TEPPER MA, FAITH A, HIGGINS JA, LAMB JR, GEHA RS. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J Immunol 1994:153:3908.
42. MARKMANN JF, JACOBSON JD, KIUMURA H, CHOTI MA, HICKEY WF, FOX IJ, SILVERS WK, BARKER CF, NAJI A. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 1989:48:478.
43. NAUME B, ESPEVIK T. Immunoregulatory effects of cytokines on natural killer cells. Scand J Immunol 1994:40:128.
44. SUZUKI S. Deoxyspergualin. Mode of action and clinical trials. Ann NY Acad Sci 1993:696:263.
45. HARDING B, MACLENNAN I. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology 1972:23:35.
46. DENNERT G. Effector mechanisms of cell-mediated immunity to xenogeneic antigens. J Immunol 1974:113:201.
47. MÖLLER G, SVEHAG S. Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody coated target cells. Cell Immunol 1974:4:1.
48. KIRK AD, LI RA, KINCH MS, ABERNETHY KA, DOYLE C, BOLLINGER RR. The human antiporcine cellular repertoire. Transplantation 1993:55:924.